The prevalence of Alzheimer’s disease (AD) is on the rise due to the global aging population. AD is the most common cause of dementia, accounting for 60-80% of all cases, which makes it a significant health concern. In recent years, the failure to develop targeted pathological drugs has led researchers to shift their focus. The blood-brain barrier (BBB) is a specialized structure that separates the circulating blood from the brain tissue and tightly regulates the passage of molecules, ions, and cells between the blood and the brain. Through a comprehensive review of current literature, we highlight the multifaceted role of BBB dysfunction in the pathogenesis of AD and discuss the complex mechanisms involved. Changes in the structure and function of endothelial cells, pericytes, and astrocytes, along with elevated expression of the highest-risk gene APOE4 can all lead to BBB damage, thereby promoting the onset of AD. Furthermore, we explore potential therapeutic targets aimed at preserving BBB integrity and function as a means of mitigating AD progression. This review underscores the significance of ongoing research efforts in elucidating the intricate interplay between BBB integrity and AD pathology, offering valuable insights for future investigations and therapeutic strategies.